Oct. 13, 2009 (Business Wire) -- IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, plans to announce third-quarter 2009 financial results before the market opens on Thursday, October 22, 2009. Executive management will review the company’s performance during a conference call with analysts at 8:00 a.m. ET on October 22.
Participants may access the call via the following telephone numbers:
1 800 734-4208 (U.S. and Canada)
1 212 231-2902 (International)
A replay will be available beginning at 10:30 a.m. ET on October 22 until 10:30 a.m. ET on October 29 by dialing:
1 800 633-8284 (U.S. and Canada)
1 402 977-9140 (International)
Reservation number to access playback: 21439822
To listen to a live Webcast of the conference call, go to http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=67124&eventID=2480530. A replay of the presentation will be available at the site for seven days following the call.
A copy of IMS’s earnings news release, and any other financial and statistical information presented during the analyst conference call, will be made available in the “Investors” area of IMS’s website at http://www.imshealth.com.
About IMS
Operating in more than 100 countries, IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. With $2.3 billion in 2008 revenue and more than 50 years of industry experience, IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations, including product and portfolio management capabilities; commercial effectiveness innovations; managed care and consumer health offerings; and consulting and services solutions that improve productivity and the delivery of quality healthcare worldwide. Additional information is available at http://www.imshealth.com.
